Oncternal Therapeutics Inc (ONCT) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Oncternal Therapeutics Inc   (NASDAQ: ONCT)

Oncternal Therapeutics Inc

Officers & Directors


James B. Breitmeyer, M.D., Ph.D.
President, Chief Executive Officer and Member of the Board of Directors

Richard G. Vincent
Chief Financial Officer

Michael G. Carter
Director

Daniel L. Kisner
Director

William R. LaRue
Director

Robert Wills
Director

Jill DeSimone
Director

Charles P. Theuer
Director

David F. Hale
Chairman of the Board of Directors

Rosemary Mazanet
Director

Xin Nakanishi
Director

BDO USA, P.C.
We have served as the Company. ,

Oncternal Therapeutics Inc currently has 24 employees.






ONCT Management Effectiveness ONCT Revenue per Employee ONCT Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.